There are many biological steps between viral infection of CD4 þ T cells and the production of HIV-1 virions. Here we incorporate an eclipse phase, representing the stage in which infected T cells have not started to produce new virus, into a simple HIV-1 model. Model calculations suggest that the quicker infected T cells progress from the eclipse stage to the productively infected stage, the more likely that a viral strain will persist. Long-term treatment effectiveness of antiretroviral drugs is often hindered by the frequent emergence of drug resistant virus during therapy. We link drug resistance to both the rate of progression of the eclipse phase and the rate of viral production of the resistant strain, and explore how the resistant strain could evolve to maximize its within-host viral fitness. We obtained the optimal progression rate and the optimal viral production rate, which maximize the fitness of a drug resistant strain in the presence of drugs. We show that the window of opportunity for invasion of drug resistant strains is widened for a higher level of drug efficacy provided that the treatment is not potent enough to eradicate both the sensitive and resistant virus. Published by Elsevier Ltd.
Introduction
Mathematical models have proven valuable in the understanding of human immunodeficiency virus type 1 (HIV-1) dynamics, disease progression and antiretroviral responses (see reviews in Nowak and May (2000) , Perelson (2002),Callaway and Perelson (2002) , Perelson and Nelson (1999, 2002) ). Many important insights into the host-pathogen interaction in HIV-1 infection have been derived from mathematical modeling and analyses of changes in the level of HIV-1 RNA in plasma when antiretroviral drugs are administered to perturb the equilibrium between viral production and viral clearance in infected individuals (Ho et al., 1995; Perelson et al., 1996 Perelson et al., , 1997 Wei et al., 1995) .
In a basic HIV model that has been frequently used to describe virus infection, there are three variables: uninfected CD4 þ T cells, productively infected T cells, and free virus (Nowak and May, 2000; Perelson et al., 1996) . In this model, infected cells are assumed to produce new virions immediately after target cells are infected by a free virus. However, there are many biological processes between viral infection and subsequent production within a cell. For example, after viral entry into the host cell, the viral RNA genome is reverse transcribed into a complementary DNA sequence by the enzyme reverse transcriptase (RT). The DNA copy of the viral genome is then imported into the nucleus and integrated into the genome of the lymphocyte. When the infected lymphocyte is activated, the viral genome is transcribed back into RNA. These RNAs are translated into proteins that require a viral protease to cleave them into active forms. Finally, the mature proteins assemble with the viral RNA to produce new virus particles 
